Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, exhibits minimal immunogenicity in patients with moderate-to-severe plaque psoriasis

K. Reich, A. Blauvelt, A. Armstrong, R. G. Langley, T. Fox, J. Huang, C. Papavassilis, E. Liang, P. Lloyd, G. Bruin

Research output: Contribution to journal › Article › peer-review

52 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, exhibits minimal immunogenicity in patients with moderate-to-severe plaque psoriasis'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology